RE:RE:RE:RE:RE:Get ready for more merger mania in the pharma sector Here is another perspective on strategy.
While I would love to sell my shares to some big pharma for, say, $90 per share, which is about $5 bill in a buyout, we need to acknowledge the share price is now $1.70 Cdn. Even if the world accepts the true (subjective) npv is over $90 a share, a mechanism would be needed for the share price to rise wildly to get to $90. Perhaps the partnering approach is a way to get the share price up fast. Then after we do some partnerships, and the share price goes up a huge amount as a result, we take an otffer from one of our partners for a total buyout of the ONCY assets.
This two part strategy may be the sequential game theory result that gets us the highest price when the total buyout occurs.